Cite
Effectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare Beneficiaries
MLA
Til Stürmer, et al. Effectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare Beneficiaries. Sept. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8272e6e2fe4e4d4700e4d06aefe0e3f3&authtype=sso&custid=ns315887.
APA
Til Stürmer, Jennifer L. Lund, Joseph M. Stavas, Hanna K. Sanoff, & YunKyung Chang. (2015). Effectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare Beneficiaries.
Chicago
Til Stürmer, Jennifer L. Lund, Joseph M. Stavas, Hanna K. Sanoff, and YunKyung Chang. 2015. “Effectiveness of Initial Transarterial Chemoembolization for Hepatocellular Carcinoma Among Medicare Beneficiaries,” September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8272e6e2fe4e4d4700e4d06aefe0e3f3&authtype=sso&custid=ns315887.